CLINICAL RESEARCH OPTIMIZED Trademark

Trademark Overview


On Friday, June 1, 2018, a trademark application was filed for CLINICAL RESEARCH OPTIMIZED with the United States Patent and Trademark Office. The USPTO has given the CLINICAL RESEARCH OPTIMIZED trademark a serial number of 87945098. The federal status of this trademark filing is REGISTERED as of Tuesday, January 29, 2019. This trademark is owned by BIORASI, LLC. The CLINICAL RESEARCH OPTIMIZED trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consultation in the field of clinical trials and development, biosimilar trials, clinical services, program development, regulatory guidance and compliance, safety and pharmacovigilance, data science and biometrics; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services; Business management and consultation in the field of clinical trials and development, biosimilar trials, clinical services, program development, regulatory guidance and compliance, safety and pharmacovigilance, data science and biometrics; Business project management services; Interactive record-keeping services for use in risk management and regulatory compliance by ...
clinical research optimized

General Information


Serial Number87945098
Word MarkCLINICAL RESEARCH OPTIMIZED
Filing DateFriday, June 1, 2018
Status700 - REGISTERED
Status DateTuesday, January 29, 2019
Registration Number5666187
Registration DateTuesday, January 29, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements


Goods and ServicesBusiness consultation in the field of clinical trials and development, biosimilar trials, clinical services, program development, regulatory guidance and compliance, safety and pharmacovigilance, data science and biometrics; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services; Business management and consultation in the field of clinical trials and development, biosimilar trials, clinical services, program development, regulatory guidance and compliance, safety and pharmacovigilance, data science and biometrics; Business project management services; Interactive record-keeping services for use in risk management and regulatory compliance by insurers and professionals in the medical field; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval
Disclaimer with Predetermined Text"CLINICAL RESEARCH"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, June 8, 2018
Primary Code035
First Use Anywhere DateWednesday, October 1, 2014
First Use In Commerce DateWednesday, October 1, 2014

Trademark Owner History


Party NameBIORASI, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAventura, FL 33180

Party NameBIORASI, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAventura, FL 33180

Party NameBIORASI, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAventura, FL 33180

Trademark Events


Event DateEvent Description
Thursday, February 29, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 29, 2024TEAS SECTION 8 RECEIVED
Monday, January 29, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 30, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 29, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 11, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 8, 2018ASSIGNED TO LIE
Friday, September 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 21, 2018EXAMINER'S AMENDMENT ENTERED
Friday, September 21, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 21, 2018EXAMINERS AMENDMENT E-MAILED
Friday, September 21, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, September 20, 2018ASSIGNED TO EXAMINER
Friday, June 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 5, 2018NEW APPLICATION ENTERED